Home » Topics » Regulatory

Regulatory
RSS

FDA approves Keytruda for classical Hodgkin's lymphoma

March 15, 2017

FDA approves Kisqali for HR+/HER2- breast cancer

March 14, 2017

First European approval of new breast cancer indication for Decapeptyl

March 13, 2017

FDA approves Xermelo for carcinoid syndrome diarrhea

March 1, 2017

EC approves Revlimid in new indication

Feb. 27, 2017

FDA approves Revlimid as maintenance therapy in multiple myeloma after autologous HSCT

Feb. 23, 2017

Truxima becomes the first biosimilar MAb in oncology to be granted E.U. marketing authorization

Feb. 23, 2017

European Commission approves Olumiant for rheumatoid arthritis

Feb. 14, 2017

Marathon Pharmaceuticals' Emflaza approved by FDA for DMD

Feb. 10, 2017

FDA grants accelerated approval to Opdivo in metastatic urothelial carcinoma

Feb. 3, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...